$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How much does a box of the new lung cancer drug Icotinib cost? Can the targeted drug icotinib be purchased in domestic pharmacies?
2025-10-19 11:44:20
Check Details
Nivolumab/ipilimumab combination chemotherapy can treat advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
CLN-081 shows anti-tumor activity in first-in-human trial for treatment of mutation-positive non-small cell lung cancer_Canghule
2025-10-19 11:44:20
Check Details
Rybrevant, the first targeted therapy for refractory lung cancer, is here
2025-10-19 11:44:20
Check Details
Rybrevant, a new drug for non-small cell lung cancer, was approved for marketing, and when Rybrevant will be launched
2025-10-19 11:44:20
Check Details
Has the imported drug topotecan been approved for marketing in the country? Where can I buy topotecan?
2025-10-19 11:44:20
Check Details
[Drug Analysis] What is the difference between topotecan and irinotecan?
2025-10-19 11:44:20
Check Details
What cancer does the new anti-tumor drug topotecan treat? Is topotecan useful in small cell lung cancer?
2025-10-19 11:44:20
Check Details
How to buy topotecan? Is topotecan included in medical insurance?
2025-10-19 11:44:20
Check Details
Application of prexitinib in advanced RET fusion-positive NSCLC
2025-10-19 11:44:20
Check Details
FDA approves first targeted therapy for subgroup of non-small cell lung cancer_Cornhule
2025-10-19 11:44:20
Check Details
AMG510: The world's first KRAS-targeted drug for lung cancer is launched shockingly
2025-10-19 11:44:20
Check Details
1
2
...
3935
3936
3937
3938
3939
3940
3941
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
2
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
3
A Revolutionary Targeted Therapy for Hematological Malignancies
4
A New Option for Advanced Renal Cell Carcinoma Treatment
5
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
6
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
7
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
8
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
9
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
10
Comprehensive Analysis of the Third-Generation EGFR-TKI
11
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
12
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison